+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06571227

Determining Important Clinical Values of the Lysholm Knee Score for Adults Undergoing Anterior Cruciate Ligament Reconstruction

Led by Kırklareli University · Updated on 2026-01-30

69

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Researchers are studying patients who will have anterior cruciate ligament ACL reconstruction surgery to better understand important clinical values related to the Lysholm Knee Score. This observational study aims to find the minimal clinically important difference and substantial clinical benefit values of this score. It also seeks to identify risk factors that may prevent patients from reaching these key improvement levels after ACL reconstruction. Participants in this study are patients scheduled to undergo ACL reconstruction surgery due to ACL rupture. The study observes their functional level before the surgery and again three months after the surgery to assess changes. No additional treatments or interventions are assigned since this is an observational study focusing on natural recovery and outcomes. During the study, participants will be evaluated using the Lysholm Knee Score at two time points before surgery and three months afterward. Researchers will collect data on functional improvements and analyze risk factors related to recovery. The total participation time covers the period from before surgery to the three-month follow-up assessment. The study is sponsored by Krklareli University and aims to provide insights to improve patient care after ACL reconstruction.

CONDITIONS

Brief Title

Establishing the Clinical Significance Values of the Lysholm Knee Score

Research Team

O

Ozan Gür, MSc

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here